4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003492
Chief Financial Officer sold 75,000 shares at an average $62.59 ($4,694,543)
- Chief Financial Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-12 | Exercise or conversion : show line 1 in the form | +75,000 | $6.32 | $474,000 | 76,000 | D |
| 2021-01-12 | Sale : show line 2 in the form | −39,973 | $62.25 | $2,488,319 | 36,027 | D |
| 2021-01-12 | Sale : show line 3 in the form | −33,827 | $62.96 | $2,129,748 | 2,200 | D |
| 2021-01-12 | Sale : show line 4 in the form | −1,200 | $63.73 | $76,476 | 1,000 | D |
| Open-market sales · 75,000 sh · avg $62.59 · $4,694,543 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-12 | Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) | −75,000 | 415,000 | D |
Loading xslF345X03/doc4.xml…